|
Volumn 22, Issue 9, 2012, Pages 3223-3228
|
Isothiazole and isoxazole fused pyrimidones as PDE7 inhibitors: SAR and pharmacokinetic evaluation
|
Author keywords
CNS penetration; Isothiazolopyrimidone; Isoxazolopyrimidone; Parkinson's disease; Phosphodiesterase 7 inhibitors
|
Indexed keywords
ISOTHIAZOLE DERIVATIVE;
ISOXAZOLE;
PHOSPHODIESTERASE;
PHOSPHODIESTERASE 10A;
PHOSPHODIESTERASE 11A;
PHOSPHODIESTERASE 1A;
PHOSPHODIESTERASE 2A;
PHOSPHODIESTERASE 3A;
PHOSPHODIESTERASE 4D;
PHOSPHODIESTERASE 5A;
PHOSPHODIESTERASE 8A1;
PHOSPHODIESTERASE 9A2;
PHOSPHODIESTERASE VII;
PHOSPHODIESTERASE VII INHIBITOR;
PHOSPHODIESTERASE VIIA;
PHOSPHODIESTERASE VIIB;
PYRIMIDINONE DERIVATIVE;
UNCLASSIFIED DRUG;
ALKYLATION;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
AREA UNDER THE CURVE;
ARTICLE;
CENTRAL NERVOUS SYSTEM;
CYANATION;
CYCLIZATION;
DRUG METABOLISM;
DRUG PENETRATION;
DRUG STRUCTURE;
DRUG SYNTHESIS;
ENZYME ACTIVITY;
ENZYME INHIBITION;
HECK REACTION;
HUMAN;
IC 50;
LIVER MICROSOME;
MALE;
MAXIMUM PLASMA CONCENTRATION;
METHYLATION;
MITSUNOBU REACTION;
NONHUMAN;
RAT;
STRUCTURE ACTIVITY RELATION;
SUBSTITUTION REACTION;
SUZUKI REACTION;
TIME TO MAXIMUM PLASMA CONCENTRATION;
CENTRAL NERVOUS SYSTEM;
CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 7;
HUMANS;
ISOXAZOLES;
PARKINSON DISEASE;
PHARMACOKINETICS;
PHOSPHODIESTERASE INHIBITORS;
PYRIMIDINONES;
STRUCTURE-ACTIVITY RELATIONSHIP;
THIAZOLES;
|
EID: 84859865682
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2012.03.025 Document Type: Article |
Times cited : (19)
|
References (31)
|